This work is licensed under a Creative Commons Attribution 4.0 International License.
LL-1b
General Information
DRACP ID DRACP02380
Peptide Name LL-1b
Sequence FLGALWKALSHLL
Sequence Length 13
UniProt ID P80399
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| PANC-1 | Pancreatic ductal adenocarcinoma | Carcinoma | IC50=54 μM | MTT assay | 2 h | 1 |
| A549 | Lung adenocarcinoma | Carcinoma | IC50=31 μM | MTT assay | 2 h | 1 |
Hemolytic Activity Human erythrocytes: 15% Hemolysis=30 µM
Normal (non-cancerous) Cytotoxicity MCF-10A: IC50=49 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C73H113N17O15
Absent amino acids CDEIMNPQRTVY
Common amino acids L
Mass 168305
Pl 9.7
Basic residues 2
Acidic residues 0
Hydrophobic residues 9
Net charge 2
Boman Index 2086
Hydrophobicity 124.62
Aliphatic Index 165.38
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 458.33
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22526264
Title Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_13994
This work is licensed under a Creative Commons Attribution 4.0 International License.